435 related articles for article (PubMed ID: 31680420)
1. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.
Peng K; Chen WR; Xia F; Liu H; Meng XW; Zhang J; Liu HY; Xia ZY; Ji FH
J Cell Mol Med; 2020 Jan; 24(1):850-861. PubMed ID: 31680420
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine protects hippocampal neurons against hypoxia/reoxygenation-induced apoptosis through activation HIF-1α/p53 signaling.
Gao Y; Yin H; Zhang Y; Dong Y; Yang F; Wu X; Liu H
Life Sci; 2019 Sep; 232():116611. PubMed ID: 31260683
[TBL] [Abstract][Full Text] [Related]
3. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
Liu S; Ai Q; Feng K; Li Y; Liu X
Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypoxia-inducible factor 1-alpha on hypoxia/reoxygenation-induced apoptosis in primary neonatal rat cardiomyocytes.
Wang X; Ma S; Qi G
Biochem Biophys Res Commun; 2012 Jan; 417(4):1227-34. PubMed ID: 22227185
[TBL] [Abstract][Full Text] [Related]
5. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
[TBL] [Abstract][Full Text] [Related]
6. [Dexmedetomidine hydrochloride up-regulates expression of hypoxia inducible factor-1α to alleviate renal ischemiareperfusion injury in diabetic rats].
Ji Z; Wang L; Wang S; Liang G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):944-949. PubMed ID: 31511215
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury.
Zhang Y; Liu D; Hu H; Zhang P; Xie R; Cui W
Biomed Pharmacother; 2019 Dec; 120():109464. PubMed ID: 31590128
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
10. Effects of PGC1
Nie J; Ta N; Liu L; Shi G; Kang T; Zheng Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1155-1163. PubMed ID: 33268575
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine Leads to the Mitigation of Myocardial Ischemia/Reperfusion-Induced Acute Lung Injury in Diabetic Rats Via Modulation of Hypoxia-Inducible Factor-1α.
Chen S; Wu J; Yang L; Tailaiti T; Zou T; Huan Y; Wang J
Braz J Cardiovasc Surg; 2022 May; 37(3):370-379. PubMed ID: 35605218
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
14. JMJD5 attenuates oxygen-glucose deprivation and reperfusion-induced injury in cardiomyocytes through regulation of HIF-1α-BNIP3.
Zhang YN; Pang YX; Liu DW; Hu HJ; Xie RQ; Cui W
Kaohsiung J Med Sci; 2022 Jan; 38(1):38-48. PubMed ID: 34369657
[TBL] [Abstract][Full Text] [Related]
15. Astaxanthin protecting myocardial cells from hypoxia/reoxygenation injury by regulating miR-138/HIF-1α axis.
Gai YS; Ren YH; Gao Y; Liu HN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7722-7731. PubMed ID: 32744699
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 inhibits myocardial ischaemia and reperfusion injury
Yuan C; Wang H; Yuan Z
Pharmazie; 2019 Mar; 74(3):157-162. PubMed ID: 30961682
[TBL] [Abstract][Full Text] [Related]
17. Effects of Sevoflurane Pretreatment on Myocardial Ischemia-Reperfusion Injury Through the Akt/Hypoxia-Inducible Factor 1-alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.
Dong J; Xu M; Zhang W; Che X
Med Sci Monit; 2019 Apr; 25():3100-3107. PubMed ID: 31028241
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
[TBL] [Abstract][Full Text] [Related]
19. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
Zhang Y; Zhao Q; Li X; Ji F
Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
